American Indian |
Cystic fibrosis (CF) |
9 |
52784 |
17.05 |
American Indian |
Hypothyroidism, primary congenital (PCH) |
25 |
52784 |
47.36 |
American Indian |
Sickle Cell Disease |
8 |
52784 |
15.16 |
Asian Indian |
Carnitine transporter deficiency (CTD)/carnitine uptake defect (CUD) |
10 |
124895 |
8.01 |
Asian Indian |
Congenital adrenal hyperplasia, classical salt wasting (CAH) |
6 |
124895 |
4.80 |
Asian Indian |
Cystic fibrosis (CF) |
9 |
124895 |
7.21 |
Asian Indian |
Hypothyroidism, primary congenital (PCH) |
119 |
124895 |
95.28 |
Asian Indian |
Medium chain acyl-CoA dehydrogenase deficiency (MCAD Deficiency) |
7 |
124895 |
5.60 |
Black |
3-Methylcrotonyl-CoA carboxylase deficiency (3MCC deficiency) |
6 |
417395 |
1.44 |
Black |
ALD - not otherwise specified |
9 |
146183 |
6.16 |
Black |
ALD carrier (female) |
10 |
146183 |
6.84 |
Black |
Carnitine transporter deficiency (CTD)/carnitine uptake defect (CUD) |
6 |
417395 |
1.44 |
Black |
Congenital adrenal hyperplasia, classical salt wasting (CAH) |
10 |
417395 |
2.40 |
Black |
Cystic fibrosis (CF) |
26 |
417395 |
6.23 |
Black |
Hypothyroidism, primary congenital (PCH) |
71 |
417395 |
17.01 |
Black |
Medium chain acyl-CoA dehydrogenase deficiency (MCAD Deficiency) |
8 |
417395 |
1.92 |
Black |
Phenylketonuria (PKU) |
11 |
417395 |
2.64 |
Black |
Sickle Cell Disease |
809 |
417395 |
193.82 |
Black |
Very long chain acyl-CoA dehydrogenase deficiency (VLCAD deficiency) |
8 |
417395 |
1.92 |
Chinese, Japanese, Korean |
3-Methylcrotonyl-CoA carboxylase deficiency (3MCC deficiency) |
8 |
347140 |
2.30 |
Chinese, Japanese, Korean |
ALD carrier (female) |
8 |
140973 |
5.67 |
Chinese, Japanese, Korean |
Congenital adrenal hyperplasia, classical salt wasting (CAH) |
16 |
347140 |
4.61 |
Chinese, Japanese, Korean |
Hypothyroidism, primary congenital (PCH) |
173 |
347140 |
49.84 |
Chinese, Japanese, Korean |
Medium chain acyl-CoA dehydrogenase deficiency (MCAD Deficiency) |
8 |
347140 |
2.30 |
Chinese, Japanese, Korean |
Phenylketonuria (PKU) |
15 |
347140 |
4.32 |
Filipino, Laotian, Vietnamese, Cambodian, Other Southeast Asian |
Hypothyroidism, primary congenital (PCH) |
105 |
256588 |
40.92 |
Filipino, Laotian, Vietnamese, Cambodian, Other Southeast Asian |
Phenylketonuria (PKU) |
8 |
256588 |
3.12 |
Hawaiian, Guamanian, Samoan |
Hypothyroidism, primary congenital (PCH) |
7 |
12988 |
53.90 |
Hispanic |
3-Methylcrotonyl-CoA carboxylase deficiency (3MCC deficiency) |
93 |
2593521 |
3.59 |
Hispanic |
ALD - not otherwise specified |
43 |
855678 |
5.03 |
Hispanic |
ALD carrier (female) |
50 |
855678 |
5.84 |
Hispanic |
Argininosuccinyl-CoA lyase deficiency (ASAL deficiency) |
8 |
2593521 |
0.31 |
Hispanic |
Biotinidase deficiency profound (BD) |
43 |
2593521 |
1.66 |
Hispanic |
Carnitine transporter deficiency (CTD)/carnitine uptake defect (CUD) |
22 |
2593521 |
0.85 |
Hispanic |
Citrullinemia type I (argininosuccinic acid synthetase deficiency (ASAS deficiency)/CIT-1) |
16 |
2593521 |
0.62 |
Hispanic |
Congenital adrenal hyperplasia, classical salt wasting (CAH) |
131 |
2593521 |
5.05 |
Hispanic |
Congenital adrenal hyperplasia, classical simple virilizing (CAH) |
15 |
2593521 |
0.58 |
Hispanic |
Cystic fibrosis (CF) |
249 |
2593521 |
9.60 |
Hispanic |
Galactosemia, classical |
23 |
2593521 |
0.89 |
Hispanic |
Glutaric acidemia type I (GA1) |
25 |
2593521 |
0.96 |
Hispanic |
Hypothyroidism, primary congenital (PCH) |
1570 |
2593521 |
60.54 |
Hispanic |
Isovaleric acidemia (IVA) |
18 |
2593521 |
0.69 |
Hispanic |
Maple syrup urine disease (MSUD) |
14 |
2593521 |
0.54 |
Hispanic |
Medium chain acyl-CoA dehydrogenase deficiency (MCAD Deficiency) |
105 |
2593521 |
4.05 |
Hispanic |
Methylmalonic acidemia mut 0 (MMA) |
13 |
2593521 |
0.50 |
Hispanic |
Methylmalonic acidemia mut- (MMA) |
6 |
2593521 |
0.23 |
Hispanic |
Phenylketonuria (PKU) |
71 |
2593521 |
2.74 |
Hispanic |
Pompe - late onset Pompe disease |
6 |
303942 |
1.97 |
Hispanic |
Propionic acidemia (PA) |
12 |
2593521 |
0.46 |
Hispanic |
SCID, severe combined immunodeficiency |
25 |
1540969 |
1.62 |
Hispanic |
Sickle Cell Disease |
64 |
2593521 |
2.47 |
Hispanic |
Very long chain acyl-CoA dehydrogenase deficiency (VLCAD deficiency) |
19 |
2593521 |
0.73 |
Middle Eastern |
Hypothyroidism, primary congenital (PCH) |
30 |
75195 |
39.90 |
Middle Eastern |
Phenylketonuria (PKU) |
10 |
75195 |
13.30 |
Other |
3-Methylcrotonyl-CoA carboxylase deficiency (3MCC deficiency) |
7 |
97996 |
7.14 |
Other |
Cystic fibrosis (CF) |
8 |
97996 |
8.16 |
Other |
Hypothyroidism, primary congenital (PCH) |
50 |
97996 |
51.02 |
Other |
Sickle Cell Disease |
21 |
97996 |
21.43 |
White |
3-Methylcrotonyl-CoA carboxylase deficiency (3MCC deficiency) |
17 |
1321415 |
1.29 |
White |
ALD - not otherwise specified |
20 |
436495 |
4.58 |
White |
ALD carrier (female) |
20 |
436495 |
4.58 |
White |
Biotinidase deficiency profound (BD) |
21 |
1321415 |
1.59 |
White |
Carnitine transporter deficiency (CTD)/carnitine uptake defect (CUD) |
21 |
1321415 |
1.59 |
White |
Congenital adrenal hyperplasia, classical salt wasting (CAH) |
48 |
1321415 |
3.63 |
White |
Congenital adrenal hyperplasia, classical simple virilizing (CAH) |
6 |
1321415 |
0.45 |
White |
Cystic fibrosis (CF) |
305 |
1321415 |
23.08 |
White |
Galactosemia, classical |
26 |
1321415 |
1.97 |
White |
Glutaric acidemia type I (GA1) |
13 |
1321415 |
0.98 |
White |
Hypothyroidism, primary congenital (PCH) |
510 |
1321415 |
38.59 |
White |
Isovaleric acidemia (IVA) |
13 |
1321415 |
0.98 |
White |
Medium chain acyl-CoA dehydrogenase deficiency (MCAD Deficiency) |
111 |
1321415 |
8.40 |
White |
Phenylketonuria (PKU) |
100 |
1321415 |
7.57 |
White |
SCID, severe combined immunodeficiency |
14 |
795061 |
1.76 |
White |
Sickle Cell Disease |
8 |
1321415 |
0.61 |
White |
Very long chain acyl-CoA dehydrogenase deficiency (VLCAD deficiency) |
10 |
1321415 |
0.76 |